Andrea Mariano
Overview
Explore the profile of Andrea Mariano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
768
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vita S, Bartoli T, Mariano A, Maffongelli G, Scorzolini L, Corpolongo A, et al.
Travel Med Infect Dis
. 2025 Jan;
64:102804.
PMID: 39874995
No abstract available.
2.
Giancola M, Haggiag S, Corpolongo A, Stasolla A, Mariano A, Menniti A, et al.
Trop Med Infect Dis
. 2024 Aug;
9(8).
PMID: 39195625
Neurocysticercosis (NCC) is caused by the larval stage of . This parasitic disease is endemic in many areas of the world and is emerging in Europe. NCC can affect different...
3.
Tetaj N, De Pascale G, Antonelli M, Vargas J, Savino M, Pugliese F, et al.
J Clin Med
. 2024 Mar;
13(6).
PMID: 38541932
Coronavirus disease 2019 (COVID-19) is a significant and novel cause of acute respiratory distress syndrome (ARDS). During the COVID-19 pandemic, there has been an increase in the incidence of cases...
4.
Rueca M, Tucci F, Mazzotta V, Gramigna G, Gruber C, Fabeni L, et al.
J Med Virol
. 2023 May;
95(5):e28791.
PMID: 37226579
Whole-genome sequencing (WGS) has been widely used for the genomic characterization and the phylogenesis of mpox virus (MPXV) 2022 multi-country outbreak. To date, no evidence has been reported on intra-host...
5.
Benvenuto D, Bartoli T, Curtolo A, Palazzolo C, Vita S, Mariano A, et al.
J Clin Med
. 2023 Jan;
12(1).
PMID: 36614934
Aero-medical evacuation has been considered as a feasible and safe treatment option during COVID pandemic, particularly when the needs of affected patients exceed what local clinics and hospitals are supposed...
6.
Mondi A, Gagliardini R, Mazzotta V, Vita S, Carletti F, Pinnetti C, et al.
J Infect
. 2022 Nov;
86(1):66-117.
PMID: 36347428
No abstract available.
7.
Farroni C, Aiello A, Picchianti-Diamanti A, Lagana B, Petruccioli E, Agrati C, et al.
Int J Infect Dis
. 2022 Nov;
125:195-208.
PMID: 36328289
Objectives: To characterize the kinetics of humoral and T-cell responses in rheumatoid arthritis (RA)-patients followed up to 4-6 weeks (T3) after the SARS-CoV-2 vaccine booster dose. Methods: Health care workers...
8.
Giancola M, Corpolongo A, Visco Comandini U, Del Nonno F, Montalbano M, Petrone A, et al.
J Antimicrob Chemother
. 2022 Sep;
77(12):3515-3517.
PMID: 36173378
No abstract available.
9.
Vita S, Rosati S, Bartoli T, Beccacece A, DAbramo A, Mariano A, et al.
Pathogens
. 2022 Aug;
11(8).
PMID: 36015003
Monoclonal antibodies are laboratory-made proteins that mimic the immune system's ability to fight off harmful microorganisms, including viruses such as Severe Acute Respiratory Syndrome-CoronaVirus-2 (SARS-CoV-2). The US Food and Drug...
10.
Mazzotta V, Cozzi-Lepri A, Colavita F, Lanini S, Rosati S, Lalle E, et al.
Front Immunol
. 2022 May;
13:868020.
PMID: 35514955
Objectives: Comparative analysis between different monoclonal antibodies (mAbs) against SARS-CoV-2 are lacking. We present an emulation trial from observational data to compare effectiveness of Bamlanivimab/Etesevimab (BAM/ETE) and Casirivimab/Imdevimab (CAS/IMD) in...